In AD patients, it has been found that the progression of cognitive impairment is related to Th17 cells and c-Jun N-terminal kinase (JNK) pathway-associated phosphatase (JKAP), which plays a key role in regulating inflammation and immune responses. This evidence concerns the gene DUSP22 and Alzheimer disease.